MDMA (designer drug)

Over several decades, the National Institute of Justice (NIJ) has made significant contributions to the field of reentry, specifically what works for whom and when. In recent years, however, the global pandemic has made it increasingly difficult to conduct research on and with populations involved with the justice system. During this time, many researchers assessing various justice-related outcomes were unable to continue their inquiries as planned due to a lack of access to their populations of interest, forcing many to pivot and rethink their research designs.